Myriad Genetics
MYGN
$18.51
Share price
-0.70%
Change (1 day)
-14.62%
Change (1 year)
EPS for Myriad Genetics (MYGN)
EPS in 2023 (TTM): -$3.04
According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -$3.04. In 2022 the company made an earnings per share (EPS) of -$1.39 a decrease over its 2021 EPS that were of -$0.37.
EPS history for Myriad Genetics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.04 | 118.71% |
| 2022 | -$1.39 | 275.68% |
| 2021 | -$0.37 | -87.99% |
| 2020 | -$3.08 | 755.56% |
| 2019 | -$0.36 | -194.74% |
| 2018 | $0.38 | -79.89% |
| 2017 | $1.89 | 112.36% |
| 2016 | $0.89 | -35.97% |
| 2015 | $1.39 | -7.33% |
| 2014 | $1.50 | -37.24% |
| 2013 | $2.39 | 59.33% |
| 2012 | $1.50 | 20.97% |
| 2011 | $1.24 | -10.79% |
| 2010 | $1.39 | 14.88% |
| 2009 | $1.21 | 12.04% |
| 2008 | $1.08 | -454.1% |
| 2007 | -$0.30 | -42.45% |
| 2006 | -$0.53 | -8.62% |
| 2005 | -$0.58 | -18.88% |
| 2004 | -$0.72 | 22.22% |
| 2003 | -$0.58 | 25.81% |
| 2002 | -$0.46 | 200% |
| 2001 | -$0.16 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $2.97 | -197.77% | 🇺🇸 USA |
 Exact Sciences EXAS | -$1.59 | -47.84% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -125.61% | 🇺🇸 USA |
 Biocept
BIOC | -$50.90 | 1,574.34% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -$5.72 | 88.16% | 🇺🇸 USA |